Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Director/PDMR Shareholding
-
Allotment of Shares under DRIS
-
Unusual Machines Participating in Upcoming August Investor Conferences
-
Issue of Equity
-
Admission to Trading on the Main Market and AIM Cancellation
-
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
General Fusion to Participate in Canaccord Genuity Growth Conference
-
Enablence Technologies Engages Canaccord Genuity as Market Maker
-
International Frontier Resources Corporation and Kinjal Corporation Announce Closing of Final Tranche of Equity Financing for Aggregate Gross Proceeds of C$38 Million
-
Pega to Present at Upcoming Investor Conferences
-
Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference
-
GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference
-
Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference
-
Amprius Technologies Sets Upcoming Conference Schedule
-
ASP Isotopes to Participate in Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026
-
Horizon Aircraft to Participate in August Investment Conferences
-
Gilat to Present at Upcoming Investor Conferences
-
BlackSky to Participate at Two Upcoming Investor Conferences
-
Mobileye Announces Participation in Upcoming Third Quarter 2026 Investor Conferences
-
Form 8.3 - [ANIMALCARE GROUP PLC - 29 07 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 29 07 2026] - (CGWL)
-
Interim Management Statement Q3 2026
-
Sprott Physical Copper Trust Updates Its “At-The-Market” Equity Program
-
OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Guardant Health to Participate in Upcoming Investor Conferences
-
TriSalus Life Sciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Shoulder Innovations to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Discovery 2026 Short Duration LP Closing August 12, 2026 – Maximum $35,000,000
-
Claranova: FY 2025-2026 Revenue
-
Updated Mineral Resource Estimate and publication of Competent Persons Report
-
Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
-
Advantage Solutions to Participate in The Canaccord Annual Growth Conference on August 12, 2026
-
Scholar Rock to Present at the Canaccord Genuity 46th Annual Growth Conference
-
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
-
Publication of Prospectus
-
908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
QuantumCore to Present at Canaccord Genuity's 46th Annual Growth Conference
-
BlackBerry to Participate in Canaccord Genuity's 46th Annual Growth Conference
-
Form 8.3 - [ANIMALCARE GROUP PLC - 28 07 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 28 07 2026] - (CGWL)
-
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
-
Cipher Digital Announces Participation in Upcoming Investor and Industry Conferences
-
Artivion to Participate in Upcoming Investor Conferences
-
1stDibs to Participate in Upcoming Investor Conference
-
REPAY to Attend Upcoming Investor Conferences
-
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
-
Veracyte to Participate in Upcoming Investor Conferences

